PerkinElmer completes offer for ViaCell

By Lisa Kerner

Charlotte, N.C., Nov. 9 - PerkinElmer, Inc. said 37.9 million shares, or more than 90%, of ViaCell, Inc.'s common stock were tendered in its offer ended Nov. 8.

The $7.25-per-share cash tender offer began Oct. 12.

PerkinElmer intends to "promptly acquire" all of the remaining ViaCell shares in a short-form merger at the same $7.25 price per share, according to a company news release. ViaCell will become an indirect wholly owned subsidiary of PerkinElmer.

PerkinElmer is a Waltham, Mass.-based health sciences and photonics company. ViaCell is a biotechnology company based in Cambridge, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.